Clinical Trial Update: Carboplatin and Paclitaxel With or Without Sorafenib Tosylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating carboplatin and paclitaxel with or without sorafenib tosylate in patients with unresectable stage III or stage IV melanoma; results hav…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Mucosal Melanoma

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Nexavar (Sorafenib)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Mucosal Melanoma, Recurrent Melanoma | Phase 3 | Status: COMPLETED | Results posted: 2012-09-27